Aarti Pharmalabs Ltd. logo

Aarti Pharmalabs Ltd. (AARTIPHARM)

Market Closed
12 Dec, 22:00
MSE MSE
741. 50
-6.6
-0.88%
- Market Cap
- P/E Ratio
4% Div Yield
11,567 Volume
- Eps
748.1
Previous Close
Day Range
733.85 747.9
Year Range
550.25 971.5
Want to track AARTIPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 53 days

Summary

AARTIPHARM closed yesterday lower at ₹741.5, a decrease of 0.88% from Thursday's close, completing a monthly increase of 6.42% or ₹44.7. Over the past 12 months, AARTIPHARM stock gained 7.93%.
AARTIPHARM pays dividends to its shareholders, with the most recent payment made on Oct 20, 2025. The next estimated payment will be in In 4 months on Apr 20, 2026 for a total of ₹2.5.
The last earnings report, released on Oct 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.82%, based on the last three reports. The next scheduled earnings report is due on Feb 04, 2026.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XNSE (INR).

AARTIPHARM Chart

Aarti Pharmalabs Ltd. (AARTIPHARM) FAQ

What is the stock price today?

The current price is ₹741.50.

On which exchange is it traded?

Aarti Pharmalabs Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is AARTIPHARM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 04, 2026.

Has Aarti Pharmalabs Ltd. ever had a stock split?

No, there has never been a stock split.

Aarti Pharmalabs Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
MSE Exchange
INE0LRU01027 ISIN
India Country
2,095 Employees
15 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

Aarti Pharmalabs Limited is a prominent player in the pharmaceutical industry, operating not only within India but also on an international platform. The company is actively involved in the manufacturing and selling of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. With its comprehensive approach to pharmaceutical development and manufacturing, Aarti Pharmalabs Limited caters to a diverse range of therapeutic areas. Originally known as Aarti Organics Limited, the company underwent a name change and has been incorporated since 2019. Its headquarters are situated in Mumbai, India, positioning it strategically in one of the country’s main business hubs. The company’s extensive portfolio and its commitment to quality make it a reputable source in the pharmaceutical industry.

Products and Services

Aarti Pharmalabs Limited offers a wide array of products and services tailored to meet the varied needs of the healthcare and pharmaceutical industries. These include:

  • Active Pharmaceutical Ingredients (APIs): The company produces APIs for a variety of therapeutic areas such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications.
  • Contract Development and Manufacturing Services: Aarti Pharmalabs Limited provides comprehensive contract development and manufacturing services (CDMO) focusing on drug substance projects. This service ensures that clients receive support in developing and manufacturing pharmaceuticals in an efficient and compliant manner.
  • Pharmaceutical Intermediates: The company manufactures intermediates which are crucial for the production of APIs. These intermediates are essential in creating the active components that give medicines their therapeutic effects.
  • Xanthine Derivatives: Aarti Pharmalabs Limited specializes in the production of xanthine derivatives including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline. These derivatives are used in a variety of medical applications such as stimulants and bronchodilators.
  • Acidic and Allied Products: Apart from pharmaceuticals, the company also offers acidic and allied products such as sulphuric acid, sulphur trioxide, oleum, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. These products serve a range of purposes across different industries.

Contact Information

Address: 204, Udyog Kshetra
Phone: 91 22 6943 6100